130 related articles for article (PubMed ID: 10672528)
1. Photodynamic parameters in the chick chorioallantoic membrane (CAM) bioassay for topically applied photosensitizers.
Hammer-Wilson MJ; Akian L; Espinoza J; Kimel S; Berns MW
J Photochem Photobiol B; 1999; 53(1-3):44-52. PubMed ID: 10672528
[TBL] [Abstract][Full Text] [Related]
2. Photodynamic parameters in the chick chorioallantoic membrane (CAM) bioassay for photosensitizers administered intraperitoneally (IP) into the chick embryo.
Hammer-Wilson MJ; Cao D; Kimel S; Berns MW
Photochem Photobiol Sci; 2002 Sep; 1(9):721-8. PubMed ID: 12665312
[TBL] [Abstract][Full Text] [Related]
3. Systemic application of photosensitizers in the chick chorioallantoic membrane (CAM) model: photodynamic response of CAM vessels and 5-aminolevulinic acid uptake kinetics by transplantable tumors.
Hornung R; Hammer-Wilson MJ; Kimel S; Liaw LH; Tadir Y; Berns MW
J Photochem Photobiol B; 1999 Mar; 49(1):41-9. PubMed ID: 10365445
[TBL] [Abstract][Full Text] [Related]
4. A new drug-screening procedure for photosensitizing agents used in photodynamic therapy for CNV.
Lange N; Ballini JP; Wagnieres G; van den Bergh H
Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):38-46. PubMed ID: 11133846
[TBL] [Abstract][Full Text] [Related]
5. Combined photodynamic and photothermal induced injury enhances damage to in vivo model blood vessels.
Kelly KM; Kimel S; Smith T; Stacy A; Hammer-Wilson MJ; Svaasand LO; Nelson JS
Lasers Surg Med; 2004; 34(5):407-13. PubMed ID: 15216534
[TBL] [Abstract][Full Text] [Related]
6. Demonstration of synergistic effects of hyperthermia and photodynamic therapy using the chick chorioallantoic membrane model.
Kimel S; Svaasand LO; Hammer-Wilson M; Gottfried V; Cheng S; Svaasand E; Berns MW
Lasers Surg Med; 1992; 12(4):432-40. PubMed ID: 1379665
[TBL] [Abstract][Full Text] [Related]
7. In vivo damage to chorioallantoic membrane blood vessels by porphycene-induced photodynamic therapy.
Gottfried V; Davidi R; Averguj C; Kimel S
J Photochem Photobiol B; 1995 Oct; 30(2-3):115-21. PubMed ID: 8558365
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of vascular effect of Photodynamic Therapy in chorioallantoic membrane using different photosensitizers.
Buzzá HH; Silva LV; Moriyama LT; Bagnato VS; Kurachi C
J Photochem Photobiol B; 2014 Sep; 138():1-7. PubMed ID: 24892978
[TBL] [Abstract][Full Text] [Related]
9. Photodynamic-induced vascular damage of the chick chorioallantoic membrane model using perylenequinones.
Chin W; Lau W; Lay SL; Wei KK; Olivo M
Int J Oncol; 2004 Oct; 25(4):887-91. PubMed ID: 15375536
[TBL] [Abstract][Full Text] [Related]
10. Application of an ex ovo chicken chorioallantoic membrane model for two-photon excitation photodynamic therapy of age-related macular degeneration.
Samkoe KS; Cramb DT
J Biomed Opt; 2003 Jul; 8(3):410-7. PubMed ID: 12880346
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo photosensitizing capabilities of 5-ALA versus photofrin in vascular endothelial cells.
Chang CJ; Sun CH; Liaw LH; Berns MW; Nelson JS
Lasers Surg Med; 1999; 24(3):178-86. PubMed ID: 10229148
[TBL] [Abstract][Full Text] [Related]
12. Photodynamic effectiveness and vasoconstriction in hairless mouse skin after topical 5-aminolevulinic acid and single- or two-fold illumination.
van der Veen N; Hebeda KM; de Bruijn HS; Star WM
Photochem Photobiol; 1999 Dec; 70(6):921-9. PubMed ID: 10628304
[TBL] [Abstract][Full Text] [Related]
13. A novel assay of angiogenesis in the quail chorioallantoic membrane: stimulation by bFGF and inhibition by angiostatin according to fractal dimension and grid intersection.
Parsons-Wingerter P; Lwai B; Yang MC; Elliott KE; Milaninia A; Redlitz A; Clark JI; Sage EH
Microvasc Res; 1998 May; 55(3):201-14. PubMed ID: 9657920
[TBL] [Abstract][Full Text] [Related]
14. Cellular distribution and phototoxicity of benzoporphyrin derivative and Photofrin.
Rousset N; Vonarx V; Eléouet S; Carré J; Bourré L; Lajat Y; Patrice T
Res Exp Med (Berl); 2000 Jun; 199(6):341-57. PubMed ID: 10945652
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of contact hypersensitivity with different analogs of benzoporphyrin derivative.
Simkin GO; King DE; Levy JG; Chan AH; Hunt DW
Immunopharmacology; 1997 Oct; 37(2-3):221-30. PubMed ID: 9403341
[TBL] [Abstract][Full Text] [Related]
16. Topical aminolaevulinic acid- and aminolaevulinic acid methyl ester-based photodynamic therapy with red and violet light: influence of wavelength on pain and erythema.
Mikolajewska P; Iani V; Juzeniene A; Moan J
Br J Dermatol; 2009 Nov; 161(5):1173-9. PubMed ID: 19785604
[TBL] [Abstract][Full Text] [Related]
17. Benzophenothiazine and benzoporphyrin derivative combination phototherapy effectively eradicates large murine sarcomas.
Cincotta L; Szeto D; Lampros E; Hasan T; Cincotta AH
Photochem Photobiol; 1996 Feb; 63(2):229-37. PubMed ID: 8657737
[TBL] [Abstract][Full Text] [Related]
18. Effects of photodynamic therapy on adhesion molecules and metastasis.
Rousset N; Vonarx V; Eléouet S; Carré J; Kerninon E; Lajat Y; Patrice T
J Photochem Photobiol B; 1999; 52(1-3):65-73. PubMed ID: 10643074
[TBL] [Abstract][Full Text] [Related]
19. The chick chorioallantoic membrane (CAM) as an in vivo model for photodynamic therapy.
Gottfried V; Lindenbaum ES; Kimel S
J Photochem Photobiol B; 1992 Jan; 12(2):204-7. PubMed ID: 1619519
[No Abstract] [Full Text] [Related]
20. Encapsulation of porphyrins and chlorins in biodegradable nanoparticles: the effect of dye lipophilicity on the extravasation and the photothrombic activity. A comparative study.
Pegaz B; Debefve E; Borle F; Ballini JP; van den Bergh H; Kouakou-Konan YN
J Photochem Photobiol B; 2005 Jul; 80(1):19-27. PubMed ID: 15963434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
